Clear amniotic fluid aspiration syndrome: A novel description of an old entity
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0301595 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Pierre-Yves Robillard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Service de Néonatologie, Centre Hospitalier Universitaire Sud Réunion, Saint-Pierre Cedex, La Réunion. Hauptthemen laut MEDLINE: Amniotic Fluid, Meconium Aspiration Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Clear amniotic fluid aspiration syndrome (CAF-AS) is a very rare event occurring in 0.25% of our term clear amniotic fluids deliveries. The study’s aims were: 1. to characterize the risk factors and outcomes associated with Clear Amniotic Fluid Aspiration Syndrome and 2. to compare the outcomes of Clear Amniotic Fluid Aspiration to Meconium Aspiration.
Methods
This was an observational study over a 22-year period in a single level-3 medical center. Compared were parturient/labor characteristics and neonatal outcomes in cases with suspected Clear Amniotic Fluid Aspiration to cases suspected for Meconium Aspiration.
Results
Out of 79,620 term deliveries there were 66,705 (83.8%) clear amniotic fluids and 12,915 (16.2%) meconium stained amniotic fluid (MSAF). Of neonates born with clear amniotic fluid, 166 (0.25%) were diagnosed with Clear Amniotic Fluid Aspiration Syndrome (CAF-AS), while 202 (15.7%) of those born with MSAF, were diagnosed with aspiration syndrome (MSAF-AS). Both conditions had comparable rates of mild manifestation (67.5% vs 69.2%, p = 0.63). Persistent pulmonary hypertension (PPH) occurred 5 times less in CAF-AS than MSAF-AS (4% vs 20%, OR 0.17, P< 0.0001) Both conditions presented similar rates of surfactant without PPH (11.1% vs 13.4%, p = 0.87). There was 1 postnatal death in CAF-AS vs 10 in MSAF.
Conclusion
CAF-AS were quantitatively quite similar in terms of need of actual active intervention of the neonatologists in the delivery room (166 vs 202, i.e. in terms of numbers of cases and not prevalence) to MSAF-AS.We identified in these cases two major specific causes: hyperkinetic explosive deliveries in multiparas and long-lasting episodes of maternal hypotension due to epidural/spinal anaesthesia during labor. Out of 140 million births per year in the world, it should be of concern that 3 million cases are neglected nowadays. Future studies should evaluate if this CAF-AS should benefit from a more active intervention such as immediate endotracheal suction at birth, this clear fluid being very easy to suction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Service de Néonatologie, Centre Hospitalier Universitaire Sud Réunion, Saint-Pierre Cedex, La Réunion.
- Centre d'Etudes Périnatales Océan Indien (CEPOI), Centre Hospitalier Universitaire Sud Réunion, Saint-Pierre Cedex, La réunion.
ORCID-Profile: Pierre-Yves Robillard
Zitieren
APA
Robillard, P. Y., Bonsante, F., Boumahni, B., Staquet, P., Richard, M., Guinaud, J., Trigolet, M., Quiviger, S., & Iacobelli, S. (2024). Clear amniotic fluid aspiration syndrome: A novel description of an old entity. PLOS ONE. https://doi.org/10.1371/journal.pone.0301595
Vancouver
Robillard PY, Bonsante F, Boumahni B, Staquet P, Richard M, Guinaud J, et al. Clear amniotic fluid aspiration syndrome: A novel description of an old entity. PLOS ONE. 2024. doi:10.1371/journal.pone.0301595
BibTeX
@article{Robillard2024,
author = {Robillard, Pierre-Yves and Bonsante, Francesco and Boumahni, Brahim and Staquet, Pierre and Richard, Magali and Guinaud, Julie and Trigolet, Marine and Quiviger, Sandrine and Iacobelli, Silvia},
title = {Clear amniotic fluid aspiration syndrome: A novel description of an old entity},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0301595}
}
EUVIMED